OPCVM
Fonds |
Der. VL |
|||||
| Barclays The Dream (C) | 550,94 |
+22,41 |
-10,49 |
-12,55 |
+48,69 |
-44,93 |
| Dexia Eqs L Biotechnology C (C) | 175,23 |
+20,74 |
+27,56 |
+27,80 |
+100,94 |
+54,14 |
| Dexia Eqs L Biotechnology C (D) | 172,51 |
+20,74 |
+27,55 |
+27,79 |
+100,81 |
+54,00 |
| Dexia Eqs L Biotechnology N | 133,05 |
+20,69 |
+27,29 |
+27,68 |
+99,85 |
+52,02 |
| Lehman Bros US Real Estate EUR Adv (C) | 4,24 |
+17,28 |
+19,96 |
+7,88 |
+125,93 |
-67,50 |
| A2X Europe (C) | 184,68 |
+17,15 |
+3,59 |
-5,07 |
ND |
ND |
| Fortis Plan International Derivatives I | 8,07 |
+16,69 |
+18,22 |
+2,27 |
+160,77 |
-64,08 |
| JPM US Small Cap Growth (GBP) A (D) | 8,05 |
+16,50 |
+23,66 |
+13,22 |
+59,60 |
+18,76 |
| Fortis Plan International Derivatives A | 7,82 |
+16,44 |
+16,44 |
+1,68 |
+153,55 |
-65,19 |
| Aviva Investors Emerg Mkts Eq Sm Cap C$ | 5,04 |
+16,27 |
+21,76 |
+23,36 |
-44,53 |
ND |
| Optimiz Best Timing II C/D | 57,13 |
+16,27 |
+13,18 |
+1,72 |
+106,14 |
ND |
| Vanguard US Discoveries Inv (D) | 84,96 |
+16,19 |
+25,25 |
+20,89 |
+71,78 |
+21,97 |
| Lehman Bros US Real Estate USD I (D) | 7,57 |
+15,83 |
+15,24 |
+5,94 |
+94,67 |
-30,31 |
| Lehman Bros US Real Estate GBP I (D) | 7,13 |
+15,81 |
+17,53 |
+8,22 |
+91,25 |
-35,31 |
| Lehman Bros US Real Estate USD I (C) | 9,83 |
+15,80 |
+17,82 |
+8,47 |
+98,81 |
-26,72 |
| Lehman Bros US Real Estate USD Adv (C) | 9,58 |
+15,72 |
+17,28 |
+8,25 |
+97,11 |
-28,24 |
| Lehman Bros US Real Estate EUR I (C) | 8,58 |
+15,56 |
+17,33 |
+7,92 |
+94,47 |
-34,50 |
| SLF (Lux) Equity Biomedical R | 97,10 |
+14,86 |
+25,62 |
+23,24 |
+58,10 |
+2,38 |
| Actions Chine | ![]() |
+11,25% |
| Actions Suède Grandes Cap. | ![]() |
+10,65% |
| Actions Etats-Unis Petites Cap. | ![]() |
+8,93% |
| Actions Portugal | ![]() |
-8,22% |
| Gestion Alternative - Multi stratégies | ![]() |
-5,95% |
| Actions Italie | ![]() |
-5,28% |